Literature DB >> 15606899

Beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: binding partners processed by furin.

Louise Wickham1, Suzanne Benjannet, Edwige Marcinkiewicz, Michel Chretien, Nabil G Seidah.   

Abstract

Using a yeast two-hybrid system, we screened a human brain cDNA library for possible interacting proteins with the C-terminal cytosolic tail of the beta-secretase beta-amyloid protein converting enzyme (BACE)1. This identified seven potential candidates, including the brain-specific type II membrane protein BRI3. Co-localization and co-immunoprecipitation experiments confirmed that BACE1 and BRI3 co-localize and interact with each other via the cytosolic tail of BACE1. Furthermore, pulse and pulse-chase analyses revealed that the pro-protein convertases furin, and to a lesser extent PC7 and PC5A, process BRI3 into a C-terminal secreted approximately 4-kDa product. Thus, furin efficiently processes both pro-BACE1 and its novel interacting protein pro-BRI3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15606899     DOI: 10.1111/j.1471-4159.2004.02840.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

1.  A nonparametric approach to detect nonlinear correlation in gene expression.

Authors:  Y Ann Chen; Jonas S Almeida; Adam J Richards; Peter Müller; Raymond J Carroll; Baerbel Rohrer
Journal:  J Comput Graph Stat       Date:  2010-09-01       Impact factor: 2.302

Review 2.  Beta-secretase: structure, function, and evolution.

Authors:  Chitra Venugopal; Christina M Demos; K S Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

3.  BRI2 (ITM2b) inhibits Abeta deposition in vivo.

Authors:  Jungsu Kim; Victor M Miller; Yona Levites; Karen Jansen West; Craig W Zwizinski; Brenda D Moore; Fredrick J Troendle; Maralyssa Bann; Christophe Verbeeck; Robert W Price; Lisa Smithson; Leilani Sonoda; Kayleigh Wagg; Vijayaraghavan Rangachari; Fanggeng Zou; Steven G Younkin; Neill Graff-Radford; Dennis Dickson; Terrone Rosenberry; Todd E Golde
Journal:  J Neurosci       Date:  2008-06-04       Impact factor: 6.167

4.  Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms.

Authors:  Richard B Parsons; Gemma C Price; Joanna K Farrant; Daryl Subramaniam; Jubril Adeagbo-Sheikh; Brian M Austen
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

Review 5.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

Review 6.  BACE and gamma-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis.

Authors:  Neville Marks; Martin J Berg
Journal:  Neurochem Res       Date:  2009-09-17       Impact factor: 3.996

7.  BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels.

Authors:  Maria Tsachaki; Angeliki Fotinopoulou; Nefeli Slavi; Vasiliki Zarkou; Jorge Ghiso; Spiros Efthimiopoulos
Journal:  Curr Alzheimer Res       Date:  2013-06       Impact factor: 3.498

8.  BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2.

Authors:  Shuji Matsuda; Yukiko Matsuda; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

Review 9.  Ion channel regulation by β-secretase BACE1 - enzymatic and non-enzymatic effects beyond Alzheimer's disease.

Authors:  Sandra Lehnert; Stephanie Hartmann; Sabine Hessler; Helmuth Adelsberger; Tobias Huth; Christian Alzheimer
Journal:  Channels (Austin)       Date:  2016-06-02       Impact factor: 2.581

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.